Agilent/Dako

Melanasome

#M0634 · western blot

40
Citing papers
1.8k
Combined citations
Supplier page Find this product

Research areas

Cancer Cells and Metastasis8Melanoma and MAPK Pathways8Immunotherapy and Immune Responses8Cutaneous Melanoma Detection and Management7melanin and skin pigmentation6Cancer Immunotherapy and Biomarkers5Ocular Oncology and Treatments4CRISPR and Genetic Engineering3

Papers citing this product

1
Human CD271-Positive Melanoma Stem Cells Associated with Metastasis Establish Tumor Heterogeneity and Long-term Growth
Cancer Research·2011·325 cit.·DOI
2
Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma
Cancer Science·2009·283 cit.·DOI
3
Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex
The Journal of Experimental Medicine·2014·198 cit.·DOI
4
Tumor-associated B-cells induce tumor heterogeneity and therapy resistance
Nature Communications·2017·141 cit.·DOI
5
A genome-wide shRNA screen identifies <i>GAS1</i> as a novel melanoma metastasis suppressor gene
Genes & Development·2008·123 cit.·DOI
6
Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma
Nature Communications·2018·89 cit.·DOI
7
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
Journal for ImmunoTherapy of Cancer·2019·85 cit.·DOI
8
Activated Hepatic Stellate Cells Express Keratinocyte Growth Factor in Chronic Liver Disease
American Journal Of Pathology·2004·77 cit.·DOI
9
TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti–PD-1/anti–CTLA-4 immunotherapy
JCI Insight·2018·73 cit.·DOI
10
Oncogene abnormalities in a series of primary melanomas of the sinonasal tract: NRAS mutations and cyclin D1 amplification are more frequent than KIT or BRAF mutations
Human Pathology·2013·70 cit.·DOI
Melanasome — Evidence — PubIndex